Business News

FDA Authorizes Ecolab’s Bioquell Technology System for N95 Respirator Decontamination

ST. PAUL, Minn.–()–Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Bioquell Technology System to decontaminate specific N95 respirators.1 The EUA is for Ecolab’s Bioquell BQ-50 and Bioquell ProteQ decontamination systems and enables healthcare facilities to decontaminate respirators on-site to help address continuing respirator shortages.

Leveraging Ecolab’s leading decontamination expertise providing solutions that help prevent hospital-acquired infections in critical care areas and help ensure pharmaceutical…

Click here to view the original article.

Related Posts

You might also like ...